Anti-inflammatory cytokines in cystic fibrosis lung disease

European Respiratory Journal

Volumn 28, Issue 3, 2006, Pages 581-587

  Starosta, V ^a   Ratjen, F ^b   Rietschel, E ^c   Paul, K ^d   Griese, Matthias ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Clara cell protein; Cystic fibrosis; Inflammation; Lipoxin

Indexed keywords

CLARA CELL PROTEIN; CYTOKINE; LIPOXIN A;

ADULT; ARTICLE; BIOCHEMISTRY; CHRONIC BRONCHITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; EOSINOPHIL; HUMAN; LUNG DISEASE; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LIPOXINS; LUNG DISEASES; MALE; UTEROGLOBIN;

EID: 33751288084     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00071405     Document Type: Article

References (31)

1. Bonfield TL. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152: 2111-2118.
2. Venkatakrishnan A, Stecenko AA, King G, et al. Exaggerated activation of nuclear factor-kappaB and altered IkappaB-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 2000; 23: 396-403.
3. Moss RB, Bocian RC, Hsu YP, et al. Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR). Clin Exp Immunol 1996; 106: 374-388.
4. Karp CL, Flick LM, Park KW, et al. Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway. Nat Immunol 2004; 5: 388-392.
5. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat 2002; 68-69: 433-455.
6. McMahon B, Mitchell S, Brady HR, Godson C. Lipoxins: revelations on resolution. Trends Pharmacol Sci 2001; 22: 391-395.
7. Lesur O, Bernard A, Arsalane K, et al. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152: 290-297.
8. Boers JE, Ambergen AW, Thunnissen FB. Number and proliferation of Clara cells in normal human airway epithelium. Am J Respir Crit Care Med 1999; 159: 1585-1591.
9. Harrod KS, Mounday AD, Stripp BR, Whitsett JA. Clara cell secretory protein decreases lung inflammation after acute virus infection. Am J Physiol 1998; 275: L924-L930.
10. Bernard A, Marchandise FX, Depelchin S, Lauwerys R, Sibille Y. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992; 5: 1231-1238.
11. Chowdhury B, Mantile-Selvaggi G, Kundu GC, et al. Amino acid residues in alpha-helix-3 of human uteroglobin are critical for its phospholipase A2 inhibitory activity. Ann N Y Acad Sci 2000; 923: 307-311.
12. Pilon AL. Rationale for the development of recombinant human CC10 as a therapeutic for inflammatory and fibrotic disease. Ann N Y Acad Sci 2000; 923: 280-299.
13. Paul K, Rietschel E, Ballmann M, et al. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. Am J Respir Crit Care Med 2004; 169: 719-725.
14. Griese M, Ramakers J, Krasselt A, et al. Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am J Respir Crit Care Med 2004; 169: 822-828.
15. Griese M, Birrer P, Demirsoy A. Pulmonary surfactant in cystic fibrosis. Eur Respir J 1997; 10: 1983-1988.
16. von Mutius E, Morgan WJ. Acute, chronic, and wheezy bronchitis. In: Taussig LM, Landau LI, eds. Pediatric Respiratory Medicine. Mosby, St Louis, 1999; pp. 547-556.
17. Morgan WJ, Taussig LM. The chronic bronchitis complex in children. Pediatr Clin North Am 1984; 31: 851-864.
18. Morimoto Y, Ding L, Oyabu T, et al. Expression of Clara cell secretory protein in the lungs of rats exposed to silicon carbide whisker in vivo. Toxicol Lett 2003; 145: 273-279.
19. Andersson O, Cassel TN, Skold CM, Eklund A, Lund J, Nord M. Clara cell secretory protein. Levels in BAL fluid after smoking cessation. Chest 2000; 118: 180-182.
20. Broeckaert F, Clippe A, Knoops B, Hermans C, Bernard A. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann N Y Acad Sci 2000; 923: 68-77.
21. Hermans C, Knoops B, Wiedig M, et al. Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 1999; 13: 1014-1021.
22. Arsalane K, Broeckaert F, Knoops B, Wiedig M, Toubeau G, Bernard A. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. Am J Respir Crit Care Med 2000; 161: 1624-1630.
23. Jorens PG, Sibille Y, Goulding NJ, et al. Potential role of Clara cell protein, an endogenous phospholipase A2 inhibitor, in acute lung injury. Eur Respir J 1995; 8: 1647-1653.
24. Geerts L, Jorens PG, Willems J, De Ley M, Slegers H. Natural inhibitors of neutrophil function in acute respiratory distress syndrome. Crit Care Med 2001; 29: 1920-1924.
25. Nord M, Schubert K, Cassel TN, Andersson O, Riise GC. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients. Transplantation 2002; 73: 1264-1269.
26. Lesur O, Bernard A, Arsalane K, et al. Clara cell protein (CC-16) induces a phospholipase A2-mediated inhibition of fibroblast migration in vitro. Am J Respir Crit Care Med 1995; 152: 290-297.
27. Manjunath R, Levin SW, Kumaroo KK, et al. Inhibition of thrombin-induced platelet aggregation by uteroglobin. Biochem Pharmacol 1987; 36: 741-746.
28. Johnston CJ, Finkelstein JN, Oberdorster G, Reynolds SD, Stripp BR. Clara cell secretory protein-deficient mice differ from wild-type mice in inflammatory chemokine expression to oxygen and ozone, but not to endotoxin. Exp Lung Res 1999; 25: 7-21.
29. Johnston CJ, Mango GW, Finkelstein JN, Stripp BR. Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am J Respir Cell Mol Biol 1997; 17: 147-155.
30. Stripp BR, Reynolds SD, Plopper CG, Boe IM, Lund J. Pulmonary phenotype of CCSP/UG deficient mice: a consequence of CCSP deficiency or altered Clara cell function? Ann N Y Acad Sci 2000; 923: 202-209.
31. Wang SZ, Rosenberger CL, Bao YX, Stark JM, Harrod KS. Clara cell secretory protein modulates lung inflammatory and immune responses to respiratory syncytial virus infection. J Immunol 2003; 171: 1051-1060.